Beyond Air Inc. Reports Revenue Surge to $3.7M in FY 2025, Net Loss Narrows to $46.6M, EPS Improves to $(0.69)

Reuters
06-20
Beyond Air Inc. Reports Revenue Surge to $3.7M in FY 2025, Net Loss Narrows to $46.6M, EPS Improves to $(0.69)

Beyond Air Inc. released its financial results for the fiscal year ending March 31, 2025. The company reported a significant increase in revenue, reaching $3.7 million compared to $1.2 million for the previous year. However, the company also reported a net loss of $48.5 million, slightly improved from the $64.3 million loss in the prior year. Operating expenses were reduced to $42.9 million from $61.7 million, driven by lower research and development and selling, general, and administrative costs. The company, a commercial-stage medical device and biopharmaceutical entity, continues to face challenges reflected in its comprehensive loss, which stood at $46.7 million, compared to $60.3 million in the previous year. No specific outlook or guidance was provided in the report.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beyond Air Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-015750), on June 20, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10